These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34016557)

  • 1. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
    Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
    J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis.
    Licht JC; Seidl E; Slingers G; Waters V; de Vries R; Post M; Ratjen F; Grasemann H
    J Cyst Fibros; 2023 Sep; 22(5):888-893. PubMed ID: 36849333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
    Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
    J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
    Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
    Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections.
    Joensen O; Paff T; Haarman EG; Skovgaard IM; Jensen PØ; Bjarnsholt T; Nielsen KG
    PLoS One; 2014; 9(12):e115584. PubMed ID: 25542036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection.
    Smith D; Spaněl P; Gilchrist FJ; Lenney W
    J Breath Res; 2013 Dec; 7(4):044001. PubMed ID: 24287489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Staphylococcus aureus in cystic fibrosis patients using breath VOC profiles.
    Neerincx AH; Geurts BP; van Loon J; Tiemes V; Jansen JJ; Harren FJ; Kluijtmans LA; Merkus PJ; Cristescu SM; Buydens LM; Wevers RA
    J Breath Res; 2016 Nov; 10(4):046014. PubMed ID: 27902490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
    Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
    J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.
    Scott-Thomas AJ; Syhre M; Pattemore PK; Epton M; Laing R; Pearson J; Chambers ST
    BMC Pulm Med; 2010 Nov; 10():56. PubMed ID: 21054900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath concentration of acetic acid vapour is elevated in patients with cystic fibrosis.
    Smith D; Sovová K; Dryahina K; Doušová T; Dřevínek P; Španěl P
    J Breath Res; 2016 May; 10(2):021002. PubMed ID: 27184114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry.
    Shestivska V; Nemec A; Dřevínek P; Sovová K; Dryahina K; Spaněl P
    Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2459-67. PubMed ID: 21818806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
    Pabary R; Huang J; Kumar S; Alton EW; Bush A; Hanna GB; Davies JC
    Eur Respir J; 2016 Mar; 47(3):994-7. PubMed ID: 26846826
    [No Abstract]   [Full Text] [Related]  

  • 17. Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.
    Purcaro G; Rees CA; Melvin JA; Bomberger JM; Hill JE
    J Breath Res; 2018 Jul; 12(4):046001. PubMed ID: 29735804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry.
    Mustafina M; Silantyev A; Krasovskiy S; Chernyak A; Naumenko Z; Suvorov A; Gognieva D; Abdullaev M; Bektimirova A; Bykova A; Dergacheva V; Betelin V; Kopylov P
    Clin Chim Acta; 2024 Jun; 560():119733. PubMed ID: 38777246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis.
    Savelev SU; Perry JD; Bourke SJ; Jary H; Taylor R; Fisher AJ; Corris PA; Petrie M; De Soyza A
    Lett Appl Microbiol; 2011 Jun; 52(6):610-3. PubMed ID: 21438899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.